Johnson & Johnson announced its intent to acquire California-based Auris Health, a developer of robotic technologies, for $3.4 billion. The purchase will allow Johnson & Johnson to have access to Auris Health’s surgical robotic scope, which is used in respiratory procedures and lung cancer detection.